These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17519882)

  • 1. In focus: non-small cell lung cancer: E1505.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):206-8. PubMed ID: 17519882
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-angiogenesis drugs in lung cancer.
    Lee SM; Baas P; Wakelee H
    Respirology; 2010 Apr; 15(3):387-92. PubMed ID: 20337999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for non-small-cell lung cancer.
    Sonpavde G
    N Engl J Med; 2007 Mar; 356(13):1374; author reply 1374-5. PubMed ID: 17396304
    [No Abstract]   [Full Text] [Related]  

  • 4. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH
    N Engl J Med; 2006 Dec; 355(24):2542-50. PubMed ID: 17167137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the dose and schedule of anti-vascular endothelial growth factor antibodies in non-small-cell lung cancer.
    Klamerus JF; Brahmer JR
    Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S51-6. PubMed ID: 21884999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab for non-small-cell lung cancer.
    Sculier JP; Meert AP; Paesmans M
    N Engl J Med; 2007 Mar; 356(13):1373-4; author reply 1374-5. PubMed ID: 17396306
    [No Abstract]   [Full Text] [Related]  

  • 7. Bevacizumab for non-small-cell lung cancer.
    Garassino MC; Hollander L; Torri V
    N Engl J Med; 2007 Mar; 356(13):1373; author reply 1374-5. PubMed ID: 17392310
    [No Abstract]   [Full Text] [Related]  

  • 8. Preoperative bevacizumab in combination with paclitaxel and carboplatin in surgically resectable non-small cell lung cancer.
    Bertino E; Villalona-Calero MA; Ross P; Grever M; Otterson GA
    Ann Thorac Surg; 2011 Feb; 91(2):640. PubMed ID: 21256341
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of complete resection of non-squamous non-small-cell lung cancer after induction chemotherapy using carboplatin, paclitaxel, and bevacizumab].
    Kawaharada Y; Imai K; Minamiya Y; Saito H; Konno H; Fujishima S; Ogawa J
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1533-7. PubMed ID: 23064066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for non-small-cell lung cancer.
    Oxnard GR
    N Engl J Med; 2007 Mar; 356(13):1373; author reply 1374-5. PubMed ID: 17396305
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer.
    Bertino EM; Otterson GA
    Lung Cancer; 2010 Dec; 70(3):233-46. PubMed ID: 20888062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival with addition of bevacizumab to paclitaxel and carboplatin in elderly patients with non-small-cell lung cancer.
    Atkins CD
    J Clin Oncol; 2008 Apr; 26(12):2063-4; author reply 2064-5. PubMed ID: 18421066
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
    Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab, when added to paclitaxel/carboplatin, prolongs survival in previously untreated patients with advanced non-small-cell lung cancer: preliminary results from the ECOG 4599 trial.
    Tyagi P
    Clin Lung Cancer; 2005 Mar; 6(5):276-8. PubMed ID: 15845177
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer.
    Felip E; Rosell R; Maestre JA; Rodríguez-Paniagua JM; Morán T; Astudillo J; Alonso G; Borro JM; González-Larriba JL; Torres A; Camps C; Guijarro R; Isla D; Aguiló R; Alberola V; Padilla J; Sánchez-Palencia A; Sánchez JJ; Hermosilla E; Massuti B;
    J Clin Oncol; 2010 Jul; 28(19):3138-45. PubMed ID: 20516435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage lung cancer findings end a debate, put focus on next steps.
    McNeil C
    J Natl Cancer Inst; 2004 Jul; 96(14):1054-5. PubMed ID: 15265961
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab: optimal dose, schedule, and duration of therapy.
    Gandara DR; Sangha R; Davies AM
    Clin Lung Cancer; 2007 Nov; 8(9):522-3. PubMed ID: 18186957
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary results of neoadjuvant paclitaxel and carboplatin in the treatment of early stage non-small cell lung cancer.
    Palackdharry CS; Durham SJ; Durzinsky DS; Veltri S
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-34-S12-36. PubMed ID: 9331118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
    Pisters KM; Kris MG; Bunn PA; Johnson DH; Ruckdeschel JC; Crowley JJ; Ginsberg RJ
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-41-S12-44. PubMed ID: 9331120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.